Microbial Modulation of Insulin Sensitivity

Slides:



Advertisements
Similar presentations
Making Proteins in the Powerhouse B. Martin Hällberg, Nils-Göran Larsson Cell Metabolism Volume 20, Issue 2, Pages (August 2014) DOI: /j.cmet
Advertisements

Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
The Metabolic Basis of Pulmonary Arterial Hypertension Gopinath Sutendra, Evangelos D. Michelakis Cell Metabolism Volume 19, Issue 4, Pages (April.
Germline Energetics, Aging, and Female Infertility Jonathan L. Tilly, David A. Sinclair Cell Metabolism Volume 17, Issue 6, Pages (June 2013) DOI:
Volume 24, Issue 1, Pages (July 2016)
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Brown Fat-Derived Exosomes: Small Vesicles with Big Impact
H. pylori GPS: Modulating Host Metabolites for Location Sensing
Elaine Holmes, Jia V. Li, Julian R. Marchesi, Jeremy K. Nicholson 
Scott J. Bultman, Christian Jobin  Cell Host & Microbe 
Nicholas A. Bokulich, Martin J. Blaser  Cell Metabolism 
Herbert Tilg, Timon E. Adolph  Cell Metabolism 
All roads lead to FoxO Cell Metabolism
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Strength in Diversity Cell Host & Microbe
Jan Gruber, Brian K. Kennedy  Cell 
Volume 18, Issue 4, Pages (October 2015)
This Gut Ain’t Big Enough for Both of Us. Or Is It
Boosting Bacterial Metabolism to Combat Antibiotic Resistance
Losing weight for a better health: Role for the gut microbiota
Message in a Biota: Gut Microbes Signal to the Circadian Clock
Can Your Microbiome Tell You What to Eat?
SCFAs Take a Toll En Route to Metabolic Syndrome
From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease
Antibiotic Exposure Promotes Fat Gain
Gut Microbes Make for Fattier Fish
David R. Meldrum, M. D. , Marge A. Morris, M. Ed. , R. D. , C. D. E
Niv Zmora, David Zeevi, Tal Korem, Eran Segal, Eran Elinav 
Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome
The Human Microbiome before Birth
Volume 155, Issue 4, Pages (October 2018)
Volume 24, Issue 1, Pages (July 2016)
Volume 155, Issue 7, Pages (December 2013)
Commensal Fungi in Health and Disease
Metformin Joins Forces with Microbes
Control of Brain Development, Function, and Behavior by the Microbiome
From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease
Volume 25, Issue 3, Pages (March 2017)
Vitamin B12 as a Modulator of Gut Microbial Ecology
Heike Döppler, Peter Storz  Cell Metabolism 
TFH-IgA Responses Keep Microbiota in Check
Chad M. Trent, Martin J. Blaser  Cell Metabolism 
Autophagy: A Potential Link between Obesity and Insulin Resistance
It’s in the Milk: Feeding the Microbiome to Promote Infant Growth
Pathways in Microbe-Induced Obesity
Gut-Pancreatic Axis AMPlified in Islets of Langerhans
Branching Out for Detection of Type 2 Diabetes
Starving our Microbial Self: The Deleterious Consequences of a Diet Deficient in Microbiota-Accessible Carbohydrates  Erica D. Sonnenburg, Justin L. Sonnenburg 
Stable-Isotope Probing of Human and Animal Microbiome Function
Raymond E. Soccio, Eric R. Chen, Mitchell A. Lazar  Cell Metabolism 
Chengcheng Jin, Jorge Henao-Mejia, Richard A. Flavell  Cell Metabolism 
Microbes, Microbiota, and Colon Cancer
David R. Meldrum, M. D. , Marge A. Morris, M. Ed. , R. D. , C. D. E
Adil Mardinoglu, Jan Boren, Ulf Smith  Cell Metabolism 
Role of the Microbiota in Immunity and Inflammation
Gut Microbes Make for Fattier Fish
Varman T. Samuel, Gerald I. Shulman  Cell Metabolism 
Subhra K. Biswas, Raffaella Bonecchi  Cell Metabolism 
Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System  Thomas Siegmund Postler, Sankar Ghosh  Cell Metabolism 
Do Cancer Cells Care If Their Host Is Hungry?
Fighting Undernutrition: Don’t Forget the Bugs
Microbial Molecules from the Multitudes within Us
Volume 20, Issue 5, Pages (November 2014)
Intestinal Ecology in the Metabolic Syndrome
Microbiome as a therapeutic target in alcohol-related liver disease
Andrew D. Patterson, Peter J. Turnbaugh  Cell Metabolism 
Hap1 and GABA: Thinking about food intake
Muriel Derrien, Johan E.T. van Hylckama Vlieg  Trends in Microbiology 
Host and Microbes Date Exclusively
The Tangled Web of Signaling in Innate Immunity
Presentation transcript:

Microbial Modulation of Insulin Sensitivity Muhammad Tanweer Khan, Max Nieuwdorp, Fredrik Bäckhed  Cell Metabolism  Volume 20, Issue 5, Pages 753-760 (November 2014) DOI: 10.1016/j.cmet.2014.07.006 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Interaction between Gut Microbiota and Host Insulin Sensitivity Carbohydrate and proteins are the major components of undigested food available for gut microbial fermentation in the colon. SCFAs and colonic gases (H2, CO2, and CH4) are the major products of carbohydrate fermentation. Amino acid fermentation leads to the production of BCFAs, SCFAs, ammonia (NH3), amines (-NH2), hydrogen sulfide (H2S), phenol, and phenolic derivatives (indole and p-cresol). During fasting states, host mucus can be degraded by mucus-degrading bacteria (e.g., Akkermansia sp) and serves as essential substrate for gut microbial fermentations. Vitamin production by gut microbes may impact insulin sensitivity (IS). Drugs, such as metformin and acetaminophen, potentially modulate gut microbiota or their metabolic profiles, thus affecting IS directly or indirectly. The microbial/physiological degradation of Gram-negative bacteria contribute to the systematic increase of LPS that impairs IS. Grey lines represent microbial-derived metabolites having positive impact on IS, whereas orange lines indicate metabolites leading to a decrease IS. Cell Metabolism 2014 20, 753-760DOI: (10.1016/j.cmet.2014.07.006) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Identification and Personalized Treatments of Patients at Risk for Developing T2D Based on the Microbiota Subjects may be identified to be at risk to develop T2D based on their microbiome. Different microbiome compositions, together with classical clinical biomarkers, may potentially allow stratification to different treatments/preventions such as lifestyle interventions (yellow), specific diets and/or prebiotics (red), classical or novel probiotics (blue), a combination of diet and probiotic (purple), specific drugs (green), or bariatric surgery (blue). Cell Metabolism 2014 20, 753-760DOI: (10.1016/j.cmet.2014.07.006) Copyright © 2014 Elsevier Inc. Terms and Conditions